CYP1B1
Cytochrome P450 1B1
Also known as: CP1B, CP1B1_HUMAN, GLC3A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16678
- Gene
- CYP1B1
- Ensembl
- ENSG00000138061
- Chromosome
- 2
- Canonical length
- 543 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
543 residues, UniProt reviewed canonical sequence.
>Q16678|CYP1B1
1 MGTSLSPNDP WPLNPLSIQQ TTLLLLLSVL ATVHVGQRLL RQRRRQLRSA PPGPFAWPLI
61 GNAAAVGQAA HLSFARLARR YGDVFQIRLG SCPIVVLNGE RAIHQALVQQ GSAFADRPAF
121 ASFRVVSGGR SMAFGHYSEH WKVQRRAAHS MMRNFFTRQP RSRQVLEGHV LSEARELVAL
181 LVRGSADGAF LDPRPLTVVA VANVMSAVCF GCRYSHDDPE FRELLSHNEE FGRTVGAGSL
241 VDVMPWLQYF PNPVRTVFRE FEQLNRNFSN FILDKFLRHC ESLRPGAAPR DMMDAFILSA
301 EKKAAGDSHG GGARLDLENV PATITDIFGA SQDTLSTALQ WLLLLFTRYP DVQTRVQAEL
361 DQVVGRDRLP CMGDQPNLPY VLAFLYEAMR FSSFVPVTIP HATTANTSVL GYHIPKDTVV
421 FVNQWSVNHD PLKWPNPENF DPARFLDKDG LINKDLTSRV MIFSVGKRRC IGEELSKMQL
481 FLFISILAHQ CDFRANPNEP AKMNFSYGLT IKPKSFKVNV TLRESMELLD SAVQNLQAKE
541 TCQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP1B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 42 nTPM
- endometrium: 38 nTPM
- seminal vesicle: 37 nTPM
- cervix: 33 nTPM
- smooth muscle: 33 nTPM
- urinary bladder: 33 nTPM
Single-cell type
- neutrophils: 374 nCPM
- fibroblasts: 273 nCPM
- pituicytes/fscs: 257 nCPM
- endometrial secretory cells: 239 nCPM
- salivary duct cells: 204 nCPM
- monocytes: 186 nCPM
Immune cell
- classical monocyte: 157 nTPM
- total PBMC: 70 nTPM
- intermediate monocyte: 23 nTPM
- non-classical monocyte: 19 nTPM
- neutrophil: 6.5 nTPM
- basophil: 1.6 nTPM
Brain region
- choroid plexus: 26 nTPM
- thalamus: 21 nTPM
- cerebral cortex: 19 nTPM
- basal ganglia: 18 nTPM
- spinal cord: 13 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYP1B1.
Disease | AllUniProt
Conditions CYP1B1 is implicated in, by any mechanism.
- Anterior segment dysgenesis 6 (ASGD6) MIM:617315
- Glaucoma 3, primary congenital, A (GLC3A) MIM:231300
- Glaucoma 1, open angle, A (GLC1A) MIM:137750
Disease | GeneticClinVar
127 pathogenic / likely-pathogenic of 599 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Anterior segment dysgenesis 6
- Glaucoma 3A
- Congenital glaucoma
- CYP1B1-related glaucoma with or without anterior segment dysgenesis
- Primary congenital glaucoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.75
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- arachidonate metabolic process
- blood vessel endothelial cell migration
- blood vessel morphogenesis
- cell adhesion
- cellular response to hydrogen peroxide
- collagen fibril organization
- endothelial cell migration
- endothelial cell-cell adhesion
- epoxygenase P450 pathway
- estrogen metabolic process
- intrinsic apoptotic signaling pathway in response to oxidative stress
- membrane lipid catabolic process
- negative regulation of cell adhesion mediated by integrin
- negative regulation of cell migration
- negative regulation of cell population proliferation
- negative regulation of NF-kappaB transcription factor activity
- nitric oxide biosynthetic process
- omega-hydroxylase P450 pathway
- positive regulation of angiogenesis
- positive regulation of apoptotic process
- positive regulation of receptor signaling pathway via JAK-STAT
- positive regulation of vascular endothelial growth factor production
- regulation of reactive oxygen species metabolic process
- response to toxic substance
- retinal blood vessel morphogenesis
- retinal metabolic process
- retinol metabolic process
- steroid catabolic process
- steroid metabolic process
- sterol metabolic process
- toxin metabolic process
- trabecular meshwork development
- xenobiotic catabolic process
- xenobiotic metabolic process
- benzene-containing compound metabolic process
Molecular functions
- estrogen 16-alpha-hydroxylase activity
- estrogen 2-hydroxylase activity
- heme binding
- hydroperoxy icosatetraenoate dehydratase activity
- iron ion binding
- monooxygenase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
- steroid hydroxylase activity
- testosterone 6-beta-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP1B1 as an antibody target. Whether an autoantibody or antibody against CYP1B1 could matter depends on whether native CYP1B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP1B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP1B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...